MassMutual Private Wealth & Trust’s SpringWorks Therapeutics SWTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-27	Closed	-$1.27K	–	2458
2025 Q2	$1.27K	Sell	27 -130	-83%	-$5.78K	﹤0.01%	2066
2025 Q1	$6.93K	Buy	157 +129	+461%	+$5.94K	﹤0.01%	1446
2024 Q4	$1.01K	Buy	+28	New	+$978	﹤0.01%	2019
2024 Q3	–	Sell	-86	Closed	-$3.24K	–	2254
2024 Q2	$3.24K	Buy	86 +73	+562%	+$3.07K	﹤0.01%	1476
2024 Q1	$640	Buy	+13	New	+$601	﹤0.01%	1811
2022 Q2	–	Sell	-15	Closed	-$1K	–	1705
2022 Q1	$1K	Buy	+15	New	+$858	﹤0.01%	1428

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

MassMutual Private Wealth & Trust's SWTX Position: Q3 2025 in Review

MassMutual Private Wealth & Trust sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 27 shares — an estimated $1.27K sold.

MassMutual Private Wealth & Trust first reported a position in SWTX in Q1 2022 and held it in 6 quarters. The position peaked at $6.93K in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

MassMutual Private Wealth & Trust reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 27 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.27K.
MassMutual Private Wealth & Trust first reported a position in SpringWorks Therapeutics in Q1 2022 and held it in 6 quarters.
MassMutual Private Wealth & Trust's SpringWorks Therapeutics position peaked at $6.93K in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2025, filed 22 Oct 2025.